Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
1
Flerie
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Lift to Zenith with Novel Myeloid Engager Therapeutics. To maximize the drugability potential, we target approaches to improve clinical…
ALKemist BioVenture round $7.5M · 2 yr ago
ALKemist Bio is a biotech startup developing next-generation T cell therapies that target ALK-positive cancers. By reprogramming the immune…
Waypoint Bio11-50 employees
Waypoint Bio is a biotechnology company pioneering the next generation of cell therapies for solid tumors.
Optieum BiotechnologiesSeries A $9M · 20 mo ago • Founded 2020 • 51-200 employees • 1 role
Generate the optimized scFvs to yield CAR-T cells with robust anti-tumor effect.
Haptena Therapeutics develops next-generation immunotherapies for oncogene-driven cancers, integrating precision oncology and immune…
Ancilia Bio201-500 employees
CRISPR-mediated viral immunity. Designed by nature, harnessed by Ancilia.

Overview

LIVING CURES. • Naturally tumor targeting and oncolytic• Overcomes the suppressive tumor microenvironment• Targets multiple pathways to elicit strong anti-tumor immunity• Extensive opportunities to deliver diverse cargo.